The Dallas Heart Study firstly identified the nonsynonymous rs738409 (I148M) located in PNPLA3, which was the most important genetic variant associated with NAFLD [56]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.